Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
28.30
+0.57 (2.06%)
At close: Jun 13, 2025, 4:00 PM
27.06
-1.24 (-4.38%)
After-hours: Jun 13, 2025, 7:26 PM EDT
KNSA Stock Forecast
Stock Price Forecast
According to 5 professional analysts, the 12-month price target for KNSA stock ranges from a low of $34 to a high of $45. The average analyst price target of $38.8 forecasts a 37.10% increase in the stock price over the next year.
Price Target: $38.80 (+37.10%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 29, 2025.
Analyst Ratings
The average analyst rating for KNSA stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Maintains $40 → $45 | Strong Buy | Maintains | $40 → $45 | +59.01% | Apr 29, 2025 |
| Wedbush | Wedbush | Buy Reiterates $34 | Buy | Reiterates | $34 | +20.14% | Apr 16, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +41.34% | Mar 13, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $39 → $40 | Buy | Maintains | $39 → $40 | +41.34% | Nov 5, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $30 → $35 | Buy | Maintains | $30 → $35 | +23.67% | Oct 30, 2024 |
Financial Forecast
Revenue This Year
580.73M
from 423.24M
Increased by 37.21%
Revenue Next Year
611.64M
from 580.73M
Increased by 5.32%
EPS This Year
0.72
from -0.60
EPS Next Year
0.43
from 0.72
Decreased by -39.86%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 634.4M | 742.4M | 871.1M | ||
| Avg | 611.6M | 700.6M | 816.6M | ||
| Low | 585.1M | 646.6M | 759.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 49.9% | 21.4% | 24.3% | ||
| Avg | 44.5% | 14.5% | 16.6% | ||
| Low | 38.2% | 5.7% | 8.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.05 | 1.60 | 2.21 | ||
| Avg | 0.43 | 1.26 | 1.50 | ||
| Low | -0.23 | 0.98 | 0.82 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 269.8% | 74.5% | ||
| Avg | - | 192.2% | 18.7% | ||
| Low | - | 126.6% | -34.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.